These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 32891175)

  • 1. Type 2 diabetes and reduced exercise tolerance: a review of the literature through an integrated physiology approach.
    Nesti L; Pugliese NR; Sciuto P; Natali A
    Cardiovasc Diabetol; 2020 Sep; 19(1):134. PubMed ID: 32891175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of reduced peak oxygen consumption in subjects with uncomplicated type 2 diabetes.
    Nesti L; Pugliese NR; Sciuto P; De Biase N; Mazzola M; Fabiani I; Trico D; Masi S; Natali A
    Cardiovasc Diabetol; 2021 Jun; 20(1):124. PubMed ID: 34158062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dose-response study of aerobic training for oxygen uptake, oxidative stress and cardiac autonomic function in type 2 diabetes mellitus: study protocol for a randomized controlled trial.
    Verma S; Moiz JA; Anwer S; Alghadir AH; Hussain ME
    Trials; 2018 May; 19(1):289. PubMed ID: 29793518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exercise capacity in diabetes mellitus is predicted by activity status and cardiac size rather than cardiac function: a case control study.
    Roberts TJ; Burns AT; MacIsaac RJ; MacIsaac AI; Prior DL; La Gerche A
    Cardiovasc Diabetol; 2018 Mar; 17(1):44. PubMed ID: 29571290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of diabetes on cardiopulmonary function: the added value of a combined cardiopulmonary and echocardiography stress test.
    Pugliese NR; Pieroni A; De Biase N; Di Fiore V; Nesti L; Agostoni P; Dini FL
    Heart Fail Rev; 2023 May; 28(3):645-655. PubMed ID: 34820732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type 2 diabetes is an independent predictor of lowered peak aerobic capacity in heart failure patients with non-reduced or reduced left ventricular ejection fraction.
    Abe T; Yokota T; Fukushima A; Kakutani N; Katayama T; Shirakawa R; Maekawa S; Nambu H; Obata Y; Yamanashi K; Nakano I; Takada S; Yokota I; Okita K; Kinugawa S; Anzai T
    Cardiovasc Diabetol; 2020 Sep; 19(1):142. PubMed ID: 32950064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of diabetes and diastolic dysfunction on exercise capacity in normotensive patients without coronary artery disease.
    Gürdal A; Kasikcioglu E; Yakal S; Bugra Z
    Diab Vasc Dis Res; 2015 May; 12(3):181-8. PubMed ID: 25670849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exercise on-transition uncoupling of ventilatory, gas exchange and cardiac hemodynamic kinetics accompany pulmonary oxygen stores depletion to impact exercise intolerance in human heart failure.
    Van Iterson EH; Smith JR; Olson TP
    Acta Physiol (Oxf); 2018 Aug; 223(4):e13063. PubMed ID: 29575588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical training in patients with stable chronic heart failure: effects on cardiorespiratory fitness and ultrastructural abnormalities of leg muscles.
    Hambrecht R; Niebauer J; Fiehn E; Kälberer B; Offner B; Hauer K; Riede U; Schlierf G; Kübler W; Schuler G
    J Am Coll Cardiol; 1995 May; 25(6):1239-49. PubMed ID: 7722116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skeletal muscle microcirculatory abnormalities are associated with exercise intolerance, ventilatory inefficiency, and impaired autonomic control in heart failure.
    Manetos C; Dimopoulos S; Tzanis G; Vakrou S; Tasoulis A; Kapelios C; Agapitou V; Ntalianis A; Terrovitis J; Nanas S
    J Heart Lung Transplant; 2011 Dec; 30(12):1403-8. PubMed ID: 21982360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exercise capacity is related to attenuated responses in oxygen extraction and left ventricular longitudinal strain in asymptomatic type 2 diabetes patients.
    Van Ryckeghem L; Keytsman C; Verboven K; Verbaanderd E; Frederix I; Bakelants E; Petit T; Jogani S; Stroobants S; Dendale P; Bito V; Verwerft J; Hansen D
    Eur J Prev Cardiol; 2022 Jan; 28(16):1756-1766. PubMed ID: 33623980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A six-month exercise intervention in subclinical diabetic heart disease: effects on exercise capacity, autonomic and myocardial function.
    Sacre JW; Jellis CL; Jenkins C; Haluska BA; Baumert M; Coombes JS; Marwick TH
    Metabolism; 2014 Sep; 63(9):1104-14. PubMed ID: 24997499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Prognostic Role of Ventilatory Inefficiency and Exercise Capacity in Idiopathic Pulmonary Fibrosis.
    Vainshelboim B; Oliveira J; Fox BD; Kramer MR
    Respir Care; 2016 Aug; 61(8):1100-9. PubMed ID: 27165419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of cardiac autonomic neuropathy with subclinical myocardial dysfunction in type 2 diabetes.
    Sacre JW; Franjic B; Jellis CL; Jenkins C; Coombes JS; Marwick TH
    JACC Cardiovasc Imaging; 2010 Dec; 3(12):1207-15. PubMed ID: 21163448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiopulmonary exercise testing in systolic heart failure in 2014: the evolving prognostic role: a position paper from the committee on exercise physiology and training of the heart failure association of the ESC.
    Corrà U; Piepoli MF; Adamopoulos S; Agostoni P; Coats AJ; Conraads V; Lambrinou E; Pieske B; Piotrowicz E; Schmid JP; Seferović PM; Anker SD; Filippatos G; Ponikowski PP
    Eur J Heart Fail; 2014 Sep; 16(9):929-41. PubMed ID: 25175894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulatory and ventilatory power in diabetic patients: Secondary analysis of a randomized controlled trial.
    Santos-de-Araújo AD; Bassi-Dibai D; Veiga TP; Caruso FCR; Mendes RG; Júnior JCB; Arena R; Schwartzmann PV; Simões RP; Borghi-Silva A
    Physiother Res Int; 2020 Jul; 25(3):e1830. PubMed ID: 31883223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between diabetic complications and exercise capacity in NIDDM patients.
    Estacio RO; Regensteiner JG; Wolfel EE; Jeffers B; Dickenson M; Schrier RW
    Diabetes Care; 1998 Feb; 21(2):291-5. PubMed ID: 9539998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial Differences in Diabetic Cardiomyopathy: The ARISE-HF Trial.
    Lopez J; Liu Y; Butler J; Del Prato S; Ezekowitz JA; Lam CSP; Marwick TH; Rosenstock J; Tang WHW; Perfetti R; Urbinati A; Zannad F; Januzzi JL; Ibrahim NE
    J Am Coll Cardiol; 2024 Jul; 84(3):233-243. PubMed ID: 38986667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiopulmonary Exercise Testing in Heart Failure.
    Malhotra R; Bakken K; D'Elia E; Lewis GD
    JACC Heart Fail; 2016 Aug; 4(8):607-16. PubMed ID: 27289406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early effects of empagliflozin on exercise tolerance in patients with heart failure: A pilot study.
    Núñez J; Palau P; Domínguez E; Mollar A; Núñez E; Ramón JM; Miñana G; Santas E; Fácila L; Górriz JL; Sanchis J; Bayés-Genís A
    Clin Cardiol; 2018 Apr; 41(4):476-480. PubMed ID: 29663436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.